Comparative proteomic study reveals 17β-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease

Wen Su,Yang Wang,Xiao Jia,Wenhan Wu,Linghai Li,Xiaodong Tian,Sha Li,Chunjiong Wang,Huamin Xu,Jiaqi Cao,Qifei Han,Shimeng Xu,Yong Chen,Yanfeng Zhong,Xiaoyan Zhang,Pingsheng Liu,Jan-Åke Gustafsson,Youfei Guan

DOI: https://doi.org/10.1073/pnas.1410741111

IF: 11.1

2014-07-15

Proceedings of the National Academy of Sciences

Abstract:Significance Nonalcoholic fatty liver disease (NAFLD) is a common chronic hepatic disease affecting up to 25% of subjects in the developed world, and represents a progressive illness eventually leading to liver fibrosis and cirrhosis. This study reports an extensive set of human liver lipid droplet (LD)-associated proteins and an array of proteins differentially expressed in human NAFLD. We also uncover 17β-hydroxysteroid dehydrogenase-13, a newly identified LD-associated protein, as a pathogenic molecule in the development of NAFLD. The present study provides a potential link between LD proteins and the pathogenesis of hepatic steatosis.

multidisciplinary sciences